P196 Influenza vaccination, airways disease and the risk of COVID-19 related mortality

P196 Table 1Demonstrating Vaccine, Airways Disease and ICS Adjusted values Factor n (%) n (%) inpatient mortality OR/Coeff 95% C I p value MORTALITY VACCINE* No Vaccine 162 (35 9) 49 (11) Vaccine 289 (64 1) 111 (25) 0 99 0 62, 1 58 0 98 AIRWAY DISEASE** No Airways Disease 410 (78 4) 148 (28) Asthma 53 (10 1) 12 (2) 0 74 0 36, 1 51 0 41 COPD 60 (11 5) 26 (5) 1 12 0 63, 1 99 0 68 ICS Use• Low Dose 21 (4 0) 6 (1) Medium Dose 61 (11 6) 21 (4) 1 39 0 46, 4 20 0 56 High Dose 10 (1 90) 3 (1) 1 06 0 19, 5 80 0 94 Any ICS † 92 (17 5) 30 (6) 0 84 0 33, 2 11 0 71 Mean LENGTH OF STAY VACCINE*